Cystic Fibrosis Foundation Therapeutics Grants $1.7 Million For Development of New Antimicrobial Drug
Cystic Fibrosis, News
Cystic Fibrosis Foundation Therapeutics (CFFT) based in Maryland, and Alaxia SAS in France, have entered an agreement to help support the first-in-patient clinical trial of ALX-009, an inhaled antimicrobial drug for patients with ... Read more